CD4 and neoplasm: On the other hand, the activation of OX40 can trigger additional anti-tumoral signaling promoting Bcl-xL and Bcl-2 expression, essential for long-term T-cell survival (76) and elimination of the tumor suppressive activity of regulatory FOXP3+CD25+CD4+ T cells (77).